Introduction
On 2 January, the Italian Supreme Court put an end to the ‘latanoprost saga’ by rejecting Pfizer Italia S.r.l. (“Pfizer”)’s appeal against the Rome Court of Appeal decision ordering Pfizer to pay the Ministry of Health and the Ministry of Economy and Finance (jointly, “Italian Government”) EUR 13,360,464 as compensation for damage caused by abuse of a dominant position.
The entire summary (in English) can be read here.
